LONA

LeonaBio Inc

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: LeonaBio (LONA), Telix Pharmaceuticals (OtherTLPPF) and Chugai Pharmaceutical Co (OtherCHGCF)

• Benzinga·2d ago

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• TipRanks·4d ago

  LeonaBio price target raised to $16 from $10 at Mizuho

• TipRanks·4d ago

  LeonaBio (LONA) Gets a Buy from Mizuho Securities

• Reuters·5d ago

  U.S. RESEARCH ROUNDUP-EQT, Las Vegas Sands, Twilio

• TipRanks·04/02 06:01

  Leonabio Warns of Major Financial and Operational Risks in Lasofoxifene Program Integration

• Reuters·04/01 02:02

  LeonaBio amends 8-K to report Sermonix deal as business acquisition, adds license exhibit

• Reuters·03/31 20:13

  LeonaBio FY25 net loss widens 9% to $106 million

• Seeking Alpha·03/27 09:14

  Athira Pharma GAAP EPS of -$24.70

• Seeking Alpha·03/27 09:14

  LeonaBio GAAP EPS of -$24.70

• TipRanks·03/26 21:29

  LeonaBio Updates Investors on 2025 Results and Strategy

• Benzinga·03/26 21:15

  LeonaBio Q4 EPS $(2.77) Misses $(0.84) Estimate

• Reuters·03/26 21:11

  LeonaBio FY2025 net cash used in operations narrows 52.98% to $45.7 million; net loss per share widens to $24.70

• Reuters·03/26 21:10

  LEONABIO INC - EXPECTS PHASE 3 LASOFOXIFENE TRIAL ENROLLMENT COMPLETION IN 4Q 2026, TOPLINE DATA IN 2H 2027

• Reuters·03/26 21:10

  LEONABIO REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE